​

Aura Biosciences Ownership | Who Owns Aura Biosciences?

OverviewForecastRevenueFinancialsChart

Aura Biosciences Ownership Summary

Aura Biosciences is owned by 74.23% institutional investors, 5.08% insiders, and 20.69% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 14.00% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 11.70% of its assets in Aura Biosciences shares.

AURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAura Biosciences74.23%5.08%20.69%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Matrix capital management company, lp6.92M14.00%$52.34M
Eventide asset management5.80M11.73%$43.87M
Adage capital partners gp4.88M9.88%$36.93M
Medicxi ventures management (jersey)3.04M6.15%$22.98M
Blackrock3.01M6.08%$22.72M
Vanguard group1.77M3.57%$13.36M
Franklin resources1.45M2.94%$10.99M
Nantahala capital management1.27M2.57%$9.60M
Long focus capital management1.06M2.14%$7.99M
Goldman sachs group1.03M2.08%$7.79M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Medicxi ventures management (jersey)3.04M6.85%$22.98M
Regency capital management inc.\de765.05K3.72%$5.78M
Decheng capital515.55K1.19%$3.90M
Eventide asset management5.80M0.75%$43.87M
Nantahala capital management1.27M0.56%$9.60M
Matrix capital management company, lp6.92M0.40%$52.34M
Long focus capital management1.06M0.31%$7.99M
Adar1 capital management203.24K0.29%$1.54M
Levin capital strategies327.47K0.26%$2.48M
Tbh global asset management60.32K0.10%$456.04K

Top Buyers

HolderShares% AssetsChange
Long focus capital management1.06M0.31%561.77K
Blackrock3.01M0.00%560.52K
Adage capital partners gp4.88M0.07%420.00K
Levin capital strategies327.47K0.26%216.27K
Adar1 capital management203.24K0.29%203.24K

Top Sellers

HolderShares% AssetsChange
Jefferies financial group---222.50K
Verition fund management---151.68K
Ensign peak advisors251.91K0.00%-105.32K
Fmr230.45K0.00%-64.20K
Nantahala capital management1.27M0.56%-51.83K

New Positions

HolderShares% AssetsChangeValue
Adar1 capital management203.24K0.29%203.24K$1.54M
Corton capital25.18K0.10%25.18K$190.39K
Commonwealth equity services25.00K0.00%25.00K$189.00K
Corebridge financial24.95K0.00%24.95K$188.64K
Mirae asset global etfs17.90K0.00%17.90K$135.30K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Metropolitan life insurance co/ny-1.55K
Entrypoint capital-3.57K
Squarepoint ops-10.45K
Xtx topco-11.59K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20248613.16%36,866,668-6.95%741.16%41-8.89%2525.00%
Jun 30, 202476-3.80%39,620,9981.29%800.82%45-2.17%2011.11%
Mar 31, 2024798.22%39,115,3235.72%981.05%46-9.80%1863.64%
Dec 31, 20237312.31%36,998,81234.61%961.84%5159.38%11-42.11%
Sep 30, 2023656.56%27,486,2331.55%721.42%32-17.95%1958.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I5.80M11.70%-
iShares Russell 2000 ETF1.13M2.28%-2.55K
Franklin Biotechnology Discv A(acc)USD1.10M2.21%13.16K
Vanguard Total Stock Mkt Idx Inv1.02M2.05%171.00K
Vanguard Institutional Extnd Mkt Idx Tr633.97K1.27%-
Franklin Biotechnology Discovery A594.11K1.20%25.64K
Fidelity Small Cap Index473.96K0.96%-12.24K
iShares Russell 2000 Value ETF434.99K0.88%-
T. Rowe Price Health Sciences347.02K0.70%-6.92K
Fidelity Extended Market Index225.35K0.45%1.76K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 18, 2024Hopkins Janet Jill Chief Medical OfficerSell$110.66K
Oct 29, 2024de los Pinos Elisabet See RemarksSell$98.79K
Oct 29, 2024Elazzouzi Amy Vice President, FinanceSell$5.94K
Oct 18, 2024Feder Julie B Chief Financial OfficerSell$302.36K
Oct 18, 2024de los Pinos Elisabet See RemarksSell$300.84K

Insider Transactions Trends

DateBuySell
2024 Q4-6
2024 Q3--
2024 Q2--
2024 Q1-2
2023 Q474

AURA Ownership FAQ

Who Owns Aura Biosciences?

Aura Biosciences shareholders are primarily institutional investors at 74.23%, followed by 5.08% insiders and 20.69% retail investors. The average institutional ownership in Aura Biosciences's industry, Biotech Stocks , is 47.04%, which Aura Biosciences exceeds.

Who owns the most shares of Aura Biosciences?

Aura Biosciences’s largest shareholders are Matrix capital management company, lp (6.92M shares, 14.00%), Eventide asset management (5.8M shares, 11.73%), and Adage capital partners gp (4.88M shares, 9.88%). Together, they hold 35.61% of Aura Biosciences’s total shares outstanding.

Does Blackrock own Aura Biosciences?

Yes, BlackRock owns 6.08% of Aura Biosciences, totaling 3.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 560.52K shares, a 22.93% change.

Who is Aura Biosciences’s biggest shareholder by percentage of total assets invested?

Medicxi ventures management (jersey) is Aura Biosciences’s biggest shareholder by percentage of total assets invested, with 6.85% of its assets in 3.04M Aura Biosciences shares, valued at 22.98M$.

Who is the top mutual fund holder of Aura Biosciences shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Aura Biosciences shares, with 11.70% of its total shares outstanding invested in 5.8M Aura Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools